search
Back to results

Comparison of Colonoscopy Adenoma Detection Yield

Primary Purpose

Adenoma Colon

Status
Recruiting
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
Standard Colonoscopy
Discovery aided colonoscopy
Discovery and G-EYE
Sponsored by
Dr. Horst Schmidt Klinik GmbH
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional screening trial for Adenoma Colon

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  1. Screening and surveillance population for Adenoma and CRC.
  2. The patient must understand and sign a written informed consent for the procedure.

Exclusion Criteria:

  1. Subjects with inflammatory bowel disease;
  2. Subjects with a personal history of hereditary polyposis syndrome;
  3. Subjects with suspected chronic stricture potentially precluding complete colonoscopy;
  4. Subjects with diverticulitis or toxic megacolon;
  5. Subjects with prior colonic surgery (exclusion appendectomy)
  6. Subjects with a history of radiation therapy to abdomen or pelvis;
  7. Pregnant or lactating female subjects;
  8. Subjects who are currently enrolled in another clinical investigation.
  9. Subjects with current oral or parenteral use of anticoagulants, not considered eligible by the investigator.
  10. Subjects with recent (within the last 3 mounts) coronary ischemia or CVA (stroke)
  11. Any patient condition deemed too risky for the study by the investigator

Sites / Locations

  • Helios Dr. Horst Schmidt Kliniken Wiesbaden GmbHRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Active Comparator

Experimental

Arm Label

Standard Colonoscopy

Discovery aided colonoscopy

Discovery and G-EYE aided colonoscopy

Arm Description

Subjects will undergo colonoscopy using a standard colonoscope

Subjects will undergo colonoscopy using a a standard colonoscope and the Discovery aided colonoscopy

Subjects will undergo colonoscopy using the G-EYE Endoscope and the Discovery aided colonoscopy

Outcomes

Primary Outcome Measures

Adenoma detection yield
adenoma detection yield, represented by Adenoma Per Colonoscopy (APC), of Standard Colonoscopy, compared with APC of Discovery aided colonoscopy and further compared with APC of Discovery & G-EYE® aided colonoscopy

Secondary Outcome Measures

Adenoma Detection Rate (Discovery + G-EYE vs. Standard Colonoscopy)
Adenoma Detection Rate of Discovery and G-EYE® aided colonoscopy compared to Adenoma Detection Rate of Standard Colonoscopy
Adenoma Detection Rate (Discovery vs. Standard Colonosocopy)
Adenoma Detection Rate of Discovery aided colonoscopy compared to Adenoma Detection Rate of Standard Colonoscopy
Adenoma Per Colonoscopy (Discovery vs. Discovery + G-EYE)
Adenoma Per Colonoscopy of Discovery aided colonoscopy compared to Adenoma Per Colonoscopy of Discovery and G-EYE® aided colonoscopy

Full Information

First Posted
December 2, 2021
Last Updated
December 2, 2021
Sponsor
Dr. Horst Schmidt Klinik GmbH
search

1. Study Identification

Unique Protocol Identification Number
NCT05158725
Brief Title
Comparison of Colonoscopy Adenoma Detection Yield
Official Title
Comparison of Colonoscopy Adenoma Detection Yield of Standard Colonoscopy, Discovery Aided Colonoscopy, and Discovery and G-EYE® Aided Colonoscopy
Study Type
Interventional

2. Study Status

Record Verification Date
December 2021
Overall Recruitment Status
Recruiting
Study Start Date
November 8, 2021 (Actual)
Primary Completion Date
May 2022 (Anticipated)
Study Completion Date
June 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Dr. Horst Schmidt Klinik GmbH

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
A Prospective Randomized Comparison of colonoscopy Adenoma Detection Yield of (i) Standard Colonoscopy (SC), (ii) artificial intelligence (Discovery) aided colonoscopy, and (iii) artificial intelligence (Discovery) and permanently mounted balloon (G-EYE®) aided colonoscopy.
Detailed Description
Multi-center, three-arm, randomized, controlled, open-label study. Total of up to 1320 patients will be randomized, including up to 10% for subject drop-out, 440 to each of the three following arms (groups): Group 1 (1st arm): patients will receive standard colonoscopy (SC) Group 2 (2nd arm): patients will receive colonoscopy aided by the Discovery artificial intelligence software (DC) Group 3 (3rd arm): patients will receive colonoscopy aided by the Discovery artificial intelligence software and the G-EYE® balloon (GDC) The purpose of this study is to compare between the diagnostic yield of Standard Colonoscopy, Discovery aided colonoscopy, and Discovery & G-EYE® aided colonoscopy.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Adenoma Colon

7. Study Design

Primary Purpose
Screening
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
Multi-center, three-arm, randomized, controlled, open-label study
Masking
None (Open Label)
Allocation
Randomized
Enrollment
1320 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Standard Colonoscopy
Arm Type
Active Comparator
Arm Description
Subjects will undergo colonoscopy using a standard colonoscope
Arm Title
Discovery aided colonoscopy
Arm Type
Active Comparator
Arm Description
Subjects will undergo colonoscopy using a a standard colonoscope and the Discovery aided colonoscopy
Arm Title
Discovery and G-EYE aided colonoscopy
Arm Type
Experimental
Arm Description
Subjects will undergo colonoscopy using the G-EYE Endoscope and the Discovery aided colonoscopy
Intervention Type
Device
Intervention Name(s)
Standard Colonoscopy
Intervention Description
In this arm, subjects will undergo colonoscopy using a standard colonoscope
Intervention Type
Device
Intervention Name(s)
Discovery aided colonoscopy
Intervention Description
the Discovery is a customized detection support software, developed utilizing AI deep learning technology to support endoscopic lesion detection in the colon. In this arm, a standard colonoscope is used with the Discovery.
Intervention Type
Device
Intervention Name(s)
Discovery and G-EYE
Intervention Description
The G-EYE® Endoscope is a standard colonoscope which is remanufactured by installing the G-EYE® balloon on the distal bending section of the colonoscope. in this arm, the G-EYE® Endoscope is used with the Discovery
Primary Outcome Measure Information:
Title
Adenoma detection yield
Description
adenoma detection yield, represented by Adenoma Per Colonoscopy (APC), of Standard Colonoscopy, compared with APC of Discovery aided colonoscopy and further compared with APC of Discovery & G-EYE® aided colonoscopy
Time Frame
Upon histology results (up to 30 days)
Secondary Outcome Measure Information:
Title
Adenoma Detection Rate (Discovery + G-EYE vs. Standard Colonoscopy)
Description
Adenoma Detection Rate of Discovery and G-EYE® aided colonoscopy compared to Adenoma Detection Rate of Standard Colonoscopy
Time Frame
Upon histology results (up to 30 days)
Title
Adenoma Detection Rate (Discovery vs. Standard Colonosocopy)
Description
Adenoma Detection Rate of Discovery aided colonoscopy compared to Adenoma Detection Rate of Standard Colonoscopy
Time Frame
Upon histology results (up to 30 days)
Title
Adenoma Per Colonoscopy (Discovery vs. Discovery + G-EYE)
Description
Adenoma Per Colonoscopy of Discovery aided colonoscopy compared to Adenoma Per Colonoscopy of Discovery and G-EYE® aided colonoscopy
Time Frame
Upon histology results (up to 30 days)

10. Eligibility

Sex
All
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Screening and surveillance population for Adenoma and CRC. The patient must understand and sign a written informed consent for the procedure. Exclusion Criteria: Subjects with inflammatory bowel disease; Subjects with a personal history of hereditary polyposis syndrome; Subjects with suspected chronic stricture potentially precluding complete colonoscopy; Subjects with diverticulitis or toxic megacolon; Subjects with prior colonic surgery (exclusion appendectomy) Subjects with a history of radiation therapy to abdomen or pelvis; Pregnant or lactating female subjects; Subjects who are currently enrolled in another clinical investigation. Subjects with current oral or parenteral use of anticoagulants, not considered eligible by the investigator. Subjects with recent (within the last 3 mounts) coronary ischemia or CVA (stroke) Any patient condition deemed too risky for the study by the investigator
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Ralf Kiesslich, Prof.
Phone
+49 611 43-9002
Email
Ralf.Kiesslich@helios-gesundheit.de
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ralf Kiesslich, Prof.
Organizational Affiliation
Helios Dr. Horst Schmidt Kliniken Wiesbaden GmbH
Official's Role
Principal Investigator
Facility Information:
Facility Name
Helios Dr. Horst Schmidt Kliniken Wiesbaden GmbH
City
Wiesbaden
ZIP/Postal Code
65199
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ralf Kiesslich, Prof.
Phone
+49 611 43-9002
Email
Ralf.Kiesslich@helios-gesundheit.de

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Comparison of Colonoscopy Adenoma Detection Yield

We'll reach out to this number within 24 hrs